Histopathological characterization of ulcerated breast cancer and comparison to their non-ulcerated counterparts
- 66 Downloads
Approximately 6–15 % of breast cancer patients are diagnosed with primary ulcerated breast cancer (ULBC). ULBC is known to be associated with short recurrence free and poor overall survival. Therefore, the purpose of this study was to characterize ULBC and compare the histopathological findings with those of non-ulcerative breast cancer (NULBC). A total of 152 ULBCs were evaluated and compared to 304 consecutive non-ulcerated, age-matched breast malignancies. Patients mean age was 65 years (SD = 13.0 ULBC, SD = 14.0 NULBC). ULBC was associated with a higher rate of poorly differentiated tumors (p = <0.001), as well as larger tumor sizes (p = <0.001). As expected, the rate of axillary lymph node involvement was higher in ULBC patients (p = <0.001). In addition to that, ULBC was associated with a higher rate of triple negative breast cancer (p = 0.002), and higher Ki67 expression (p = <0.001). ULBC showed more aggressive histopathological features in comparison to NULBC which may contribute to the generally known poorer prognosis of women with ULBC.
KeywordsBreast cancer Ulcerated breast cancer Locally advanced breast cancer Prognostic factors
The authors want to thank Ms. Stefanie Mick for data input.
Conflicts of Interest
MKT, CS, and CFS participated in the design, conception, and interpretation of the study as well as proof read and drafted the manuscript.
CS and MKT wrote the manuscript.
CS, MKT, GD, MB, ZBH, and KP helped with data collection.
MS participated in the design of the study and performed the statistical analysis.
- 11.Hammond ME, Hayes DF, Wolff AC, Mangu PB, Temin S. American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract. 2010;6:195–7.CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Personalizing the treatment of women with early breast cancer: Highlights of the st gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol. 2013;24:2206–23.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med. 2010;7:e1000279.CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Haagensen C: Clinical classification of the stage of advancement of breast carcinoma. Diseases of the breast, ed 3rd ed. Philadelphia, W. B. Saunders Company, 1986.Google Scholar
- 22.AUSTRIA S: Jahrbuch der gesundheitsstatistik; in Austria S (ed), Verlag Österreich GmbH, 2012.Google Scholar
- 24.Biganzoli L, Wildiers H, Oakman C, Marotti L, Loibl S, Kunkler I, et al. Management of elderly patients with breast cancer: Updated recommendations of the international society of geriatric oncology (siog) and european society of breast cancer specialists (eusoma). Lancet Oncol. 2012;13:e148–160.CrossRefPubMedGoogle Scholar